Literature DB >> 6131814

The ontogeny of somatotropic binding sites in ovine hepatic membranes.

P D Gluckman, J H Butler, T B Elliott.   

Abstract

The binding of human [125I]GH, ovine [125I]GH, bovine [125I]GH, and ovine [125I]PRL, to hepatic microsomal membranes (100,000 g) prepared from fetal, neonatal, and infant lambs and adult ewes has been examined. The specific binding of hGH increases (P less than 0.01) from 3.4 +/- 0.8% in the fetus (n = 7) to 20.0 +/- 2.1% (n = 6) in lambs at least 6 days postpartum. The binding of oGH is low in the fetus (0.7 +/- 0.2%; n = 13) and neonatal lamb (1.3 +/- 0.5%; n = 5) and increases (P less than 0.01) in older lambs (14.6 +/- 4.7%; n = 6) and adult sheep (14.9 +/- 5.3%; n = 4). Similarly, the binding of bGH is less (P less than 0.05) to fetal tissues. In contrast, the binding of oPRL is similar in fetal and postnatal preparations. Cross-reaction studies suggest that the binding of GHs is to a site with lactogenic characteristics in the fetus. In contrast, in lambs at least 4 days postpartum and in adult sheep, binding is to a site with somatogenic characteristics. The inability to detect somatogenic sites in the fetal liver is not due to saturation by endogenous GH or chorionic somatomammotropin, as the binding characteristics do not change after MgCl2 pretreatment of the membrane fractions. No change in binding is observed 25 days after fetal decapitation at 69 days (n = 3), suggesting that circulating GH does not down-regulate the fetal GH receptor. These observations suggest an immaturity of the somatogenic receptor in the ovine fetal liver and its appearance in the perinatal period. Immaturity of this receptor is likely to be the basis for the lack of a major effect of fetal GH on fetal somatic growth.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131814     DOI: 10.1210/endo-112-5-1607

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Transcription from the P2 promoter of the growth hormone receptor gene involves members of the Sp transcription factor family.

Authors:  T E Adams
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

2.  Immunocytochemical demonstration of the binding and internalization of growth hormone in GERL of Chang hepatoma cells.

Authors:  J J Wang; J P Chang; C S Teng
Journal:  Cell Tissue Res       Date:  1990-11       Impact factor: 5.249

3.  Postnatal effects of intrauterine treatment of the growth-restricted ovine fetus with intra-amniotic insulin-like growth factor-1.

Authors:  A M Spiroski; M H Oliver; A L Jaquiery; T C R Prickett; E A Espiner; J E Harding; F H Bloomfield
Journal:  J Physiol       Date:  2017-12-27       Impact factor: 5.182

4.  Immunocytochemical demonstration of the binding of growth-related polypeptide hormones on chick embryonic tissues.

Authors:  J J Wang
Journal:  Histochemistry       Date:  1989

5.  Two forms of the prolactin receptor messenger ribonucleic acid are Present in ovine fetal liver and adult ovary.

Authors:  R V Anthony; G W Smith; A Duong; S L Pratt; M F Smith
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 6.  Interaction between endocrine and paracrine peptides in prenatal growth control.

Authors:  R D Milner; D J Hill
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

7.  Purification of a distinct placental lactogen receptor, a new member of the growth hormone/prolactin receptor family.

Authors:  M Freemark; M Comer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.